Demant Is Struggling in the US Managed Care Segment
Demant benefits from favourable trends, including an ageing population, increasing noise pollution, fairly low penetration rates in the developed world, and virtually untapped patient populations in emerging markets such as China. Demant's broad product offerings should allow the company to capitalize on these trends, while its strong brand and superior technological know-how should yield market share gains. Following the sale of its implant business and the upcoming disposition of the communications segment, Demant is in a better position to focus its efforts and maintain its top-tier positioning in the market.